Awarded contractOpenSuppliesPoland

Sukcesywne dostawy produktów farmaceutycznych dla Szpitali Pomorskich Sp. z o.o. - produkty farmaceutyczne – programy lekowe 2026v62

8 suppliers awarded•15 lots awarded•€3.00M awarded

Buyer: Szpitale Pomorskie Sp. z o.o. / Gdynia, Poland

Published Jul 13, 2026Awarded Jun 30, 2026

Pharmaceutical productsAntineoplastic and immunomodulating agents

Awarded value

€3.00M

Estimated value

€3.00M

Awarded at 100% of estimated value

Award date

Jun 30, 2026

Winners

Lots awarded

Award values

Notice total

€3.00M

Sum of lot awards

€3.20M

TED notice total and lot-level values do not exactly match.

Winners

Roche Polska Sp. z o. o.

WARSZAWA, POL

2 lots

€1.0M This contract

20 award notices•36 awarded lots•€56.02M total

CSL Behring sp. z o.o.

Warszawa, POL

3 lots

€615,158 This contract

25 award notices•37 awarded lots•€10.37M total

InPharm Sp. z o.o.

Warszawa, POL

2 lots

€551,988 This contract

7 award notices•13 awarded lots•€4.17M total

Urtica sp. z o.o.

Wrocław, POL

3 lots

€432,703 This contract

60 award notices•213 awarded lots•€218.51M total

Amgen Sp. z o.o.

WARSZAWA, POL

1 lot

€125,719 This contract

11 award notices•13 awarded lots•€1.68M total

Komtur Polska sp. z o.o.

Warszawa, POL

1 lot

€75,217 This contract

63 award notices•103 awarded lots•€51.68M total

NEUCA SPÓŁKA AKCYJNA

Toruń, POL

1 lot

€2,189 This contract

10 award notices•22 awarded lots•€3.27M total

Asclepios S.A.

WROCŁAW, POL

1 lot

€229 This contract

57 award notices•164 awarded lots•€15.22M total

Lots awarded

Lot	Winner	Award value	Main CPV
LOT-0027	Roche Polska Sp. z o. o.	€918,317	Pharmaceutical products (33600000), Antineoplastic and immunomodulating agents (33652000)
LOT-0019	InPharm Sp. z o.o.	€551,137	Pharmaceutical products (33600000), Antineoplastic and immunomodulating agents (33652000)
LOT-0025	CSL Behring sp. z o.o.	€460,070	Pharmaceutical products (33600000), Antineoplastic and immunomodulating agents (33652000)
LOT-0030	Not specified	€355,581	Pharmaceutical products (33600000), Antineoplastic and immunomodulating agents (33652000)
LOT-0021	Urtica sp. z o.o.	€196,957	Pharmaceutical products (33600000), Antineoplastic and immunomodulating agents (33652000)
LOT-0022	Urtica sp. z o.o.	€196,957	Pharmaceutical products (33600000), Antineoplastic and immunomodulating agents (33652000)
LOT-0028	Amgen Sp. z o.o.	€125,719	Pharmaceutical products (33600000), Antineoplastic and immunomodulating agents (33652000)
LOT-0020	Roche Polska Sp. z o. o.	€119,453	Pharmaceutical products (33600000), Antineoplastic and immunomodulating agents (33652000)
LOT-0026	CSL Behring sp. z o.o.	€79,188	Pharmaceutical products (33600000), Antineoplastic and immunomodulating agents (33652000)
LOT-0024	CSL Behring sp. z o.o.	€75,900	Pharmaceutical products (33600000), Antineoplastic and immunomodulating agents (33652000)
LOT-0029	Komtur Polska sp. z o.o.	€75,217	Pharmaceutical products (33600000), Antineoplastic and immunomodulating agents (33652000)
LOT-0010	Urtica sp. z o.o.	€38,789	Pharmaceutical products (33600000), Antineoplastic and immunomodulating agents (33652000)
LOT-0018	NEUCA SPÓŁKA AKCYJNA	€2,189	Pharmaceutical products (33600000), Antineoplastic and immunomodulating agents (33652000)
LOT-0023	InPharm Sp. z o.o.	€851	Pharmaceutical products (33600000), Antineoplastic and immunomodulating agents (33652000)
LOT-0015	Asclepios S.A.	€229	Pharmaceutical products (33600000), Antineoplastic and immunomodulating agents (33652000)